ADVANZ PHARMA Corp names new CEO
19 November 2021 -

ADVANZ PHARMA Corp. Limited, a UK-based specialty pharmaceutical company, announced on Thursday, that it has named Dr Steffen Wagner as its new chief executive officer effective early 2022.

Dr Wagner is to succeed Graeme Duncan, who will step down from his role and become a special advisor to the company's board.

Presently, Dr Wagner is a member of the executive management team at STADA Arzneimittel AG. He is a medical doctor by training and earlier held senior roles with Biogen and within the Novartis Group, and served as a consultant at McKinsey & Company and Bain & Company. He has extensive international pharma experience.